altrenogest- altrenogest powder
attix pharmaceuticals i - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altrenogest powder
medisca inc. - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altrenogest powder
darmerica, llc - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altrenogest powder
darmerica, llc - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altren- altrenogest solution
aurora pharmaceutical, inc. - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) - altrenogest 2.2 mg in 1 ml - for use in animals only for suppression of estrus in mares. suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal in mares with ovarian follicles 20 mm or greater. suppression of estrus will facilitate: • attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. • management of prolonged estrus conditions. • scheduled breeding during the physiological breeding season. for oral use in horses only altren® (altrenogest) solution 0.22% is indicated to suppress estrus in mares. suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. this facilitates the attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. suppression of estrus will also facilitate management of prolonged estrus conditions. suppression of estrus may be used to facilitate scheduled breeding during the physiological breeding season. altren® (altrenogest) sol
ovamed- altrenogest solution
bimeda, inc. - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) - altrenogest 2.2 mg in 1 ml - indications: ovamed™ (altrenogest ) solution 0.22% is indicated to suppress estrus in mares. suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. this facilitates the attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. suppression of estrus will also facilitate management of prolonged estrus conditions. suppression of estrus may be used to facilitate scheduled breeding during the physiological breeding season. contraindications: ovamed™ (altrenogest ) solution 0.22% is contraindicated for use in mares having a previous or current history of uterine inflammation (i.e., acute, subacute, or chronic endometritis). natural or synthetic gestagen therapy may exacerbate existing low-grade or “smoldering” uterine inflammation into a fulminating uterine infection in some instances.
regumate- altrenogest solution
merck sharp & dohme corp. - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) - altrenogest 2.2 mg in 1 ml - indications: for suppression of estrus in mares. suppression of estrus allows for a predictable occurrence of estrus following drug withdrawal. this facilitates the attainment of regular cyclicity during the transition from winter anestrus to the physiological breeding season. suppression of estrus will also facilitate management of prolonged estrus conditions. suppression of estrus may be used to facilitate scheduled breeding during the physiological breeding season. contraindications: do not use regu-mate® (altrenogest) in mares having a previous or current history of uterine inflammation (e.g., acute, subacute, or chronic endometritis). natural or synthetic gestagen therapy may exacerbate existing low-grade or "smoldering" uterine inflammation into a fulminating uterine infection in some instances.
altrenogest powder
letco medical, llc - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altrenogest powder
ax pharmaceutical corp - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -
altrenogest powder
euroapi france - altrenogest (unii: 2u0x0ja2nb) (altrenogest - unii:2u0x0ja2nb) -